Nephros Inc.
$4.30
$0.01 (+0.23%)
$4.24Day Range$4.48
Key Statistics
Market Cap
$46.59M
Shares Outstanding
10.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 21, 2004
Round Lot
100
Locale
US
Trading Data
Day Open
$4.30
Day High
$4.48
Day Low
$4.24
Volume
10.5K
VWAP
$4.36
Prev Close
$4.29
Transactions
--
Acc. Volume
--
About Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384136 employees380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079201.343.5202IPO Sep 21, 2004US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001196298
- Composite FIGI
- BBG000NXRTF2
- Share Class FIGI
- BBG001SL04M7
- Ticker Root
- NEPH
- SIC Code
- 3841
About Nephros Inc. (NEPH) Stock
Nephros Inc. (NEPH) closed the 2026-09-16 session at $4.30, up 0.23% versus the previous close (+0.01). The stock opened at $4.30 and traded between $4.24 and $4.48 during that session. Session trading volume was 10K shares. The volume-weighted average price (VWAP) is $4.36.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
Nephros Inc. has a market capitalization of $46.6 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. NEPH is listed on the XNAS exchange. The company employs approximately 36 people. Nephros Inc. is headquartered in SOUTH ORANGE, NJ. The recorded listing date is 2004-09-21.
On this page you can find market NEPH stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.